- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
MR procedure growth slows
The number of MR procedures is continuing to grow, especially on the heels of the increasing popularity of MR angiography. Overall procedure growth, however, has begun to slow compared with previous years' performance, according to Arlington Medical
The number of MR procedures is continuing to grow, especially on the heels of the increasing popularity of MR angiography. Overall procedure growth, however, has begun to slow compared with previous years' performance, according to Arlington Medical Resources. An estimated 24.9 million MR procedures were performed in 2003 at more than 5700 U.S. hospitals and freestanding diagnostic imaging centers, the research company said. Brain studies were the most popular. In the 3.4 million MR exams performed with contrast, Magnevist was the agent most frequently used.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
